Teresa Brophy Bair net worth and biography

Teresa Bair Biography and Net Worth

Chief Legal Officer of Kura Oncology

Teresa Bair, J.D. has served as our Chief Legal Officer since October 2021. Prior to joining us, she served as General Counsel and Senior Vice President, Administration at Athenex Inc. Previously, she was a partner at Harris Beach PLLC. Ms. Bair serves on the Boards of Directors of BirchBioMed Inc., Infinite Group, Inc. and is Board Chair of the Western New York Women’s Foundation. She also serves on the Board of Trustees of the University at Buffalo Foundation, the Board of Directors of the Bowling Green State University Foundation, and the Advisory Boards of Varia Ventures and the Buffalo Institute for Genomics & Data Analytics. She earned her J.D. from State University of New York at Buffalo School of Law and her B.S. in Business Administration from Bowling Green State University.

What is Teresa Brophy Bair's net worth?: The estimated net worth of Teresa Brophy Bair is at least $2.25 million as of November 14th, 2025. Ms. Bair owns 188,139 shares of Kura Oncology stock worth more than $2,253,905 as of December 5th. This net worth approximation does not reflect any other assets that Ms. Bair may own. Additionally, Ms. Bair receives an annual salary of $705,380.00 as Chief Legal Officer at Kura Oncology. Learn More about Teresa Brophy Bair's net worth.
How old is Teresa Brophy Bair?: Ms. Bair is currently 53 years old. There are 4 older executives and no younger executives at Kura Oncology. The oldest executive at Kura Oncology is Ms. Kathleen Ford, Chief Operating Officer, who is 77 years old. Learn More on Teresa Brophy Bair's age.
What is Teresa Brophy Bair's salary?: As the Chief Legal Officer of Kura Oncology, Inc., Ms. Bair earns $705,380.00 per year. There are 3 executives that earn more than Ms. Bair. The highest earning executive at Kura Oncology is Dr. Troy Edward Wilson J.D., Ph.D., Chairman, CEO & President, who commands a salary of $1,220,000.00 per year. Learn More on Teresa Brophy Bair's salary.
How do I contact Teresa Brophy Bair?: The corporate mailing address for Ms. Bair and other Kura Oncology executives is 12730 HIGH BLUFF DRIVE SUITE 400, SAN DIEGO CA, 92130. Kura Oncology can also be reached via phone at (858) 500-8800 and via email at [email protected]. Learn More on Teresa Brophy Bair's contact information.
Has Teresa Brophy Bair been buying or selling shares of Kura Oncology?: In the last ninety days, Teresa Brophy Bair has sold $98,428.72 in Kura Oncology stock. Most recently, Teresa Brophy Bair sold 8,804 shares of the business's stock in a transaction on Friday, November 14th. The shares were sold at an average price of $11.18, for a transaction totalling $98,428.72. Following the completion of the sale, the insider now directly owns 188,139 shares of the company's stock, valued at $2,103,394.02. Learn More on Teresa Brophy Bair's trading history.
Who are Kura Oncology's active insiders?: Kura Oncology's insider roster includes Teresa Bair (Chief Legal Officer), Thomas Doyle (SVP, Finance and Accounting), Kathleen Ford (Chief Operating Officer), Laura Johnson (Director), Mollie Leoni (Chief Medical Officer), Thomas Malley (Director), Anthony Praill (CFO), Troy Wilson (President and Chief Executive Officer), and Saiid Zarrabian (Insider). Learn More on Kura Oncology's active insiders.
Are insiders buying or selling shares of Kura Oncology?: In the last twelve months, Kura Oncology insiders bought shares 1 times. They purchased a total of 50,000 shares worth more than $410,000.00. In the last twelve months, insiders at the sold shares 16 times. They sold a total of 137,521 shares worth more than $1,308,039.69. The most recent insider tranaction occured on November, 14th when insider Teresa Brophy Bair sold 8,804 shares worth more than $98,428.72. Insiders at Kura Oncology own 6.4% of the company. Learn More about insider trades at Kura Oncology.
Information on this page was last updated on 11/14/2025.

Teresa Brophy Bair Insider Trading History at Kura Oncology

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/14/2025	Sell	8,804	$11.18	$98,428.72	188,139
9/29/2025	Sell	8,805	$8.94	$78,716.70	148,043
5/19/2025	Sell	1,559	$5.96	$9,291.64	107,948
5/20/2024	Sell	2,615	$22.15	$57,922.25	68,979
1/29/2024	Sell	2,053	$17.80	$36,543.40	68,979

Teresa Brophy Bair Buying and Selling Activity at Kura Oncology

Kura Oncology Company Overview

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, an orally bioavailable small molecule inhibitor of the menin-KMT2A interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; tipifarnib, an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a farnesyl transferase inhibitor for the treatment of solid tumors. It has a clinical collaboration with Novartis Pharma AG to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression and/or PIK3CA mutation and/or amplification. The company was founded in 2014 and is headquartered in San Diego, California.

Today's Range

Now: $11.98

$11.90

$12.32

50 Day Range

MA: $10.37

$8.85

$12.09

2 Week Range

Now: $11.98

$5.41

$12.49

Volume

1,438,355 shs

Average Volume

1,795,837 shs

Market Capitalization

$1.04 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.21

Teresa Bair Biography and Net Worth

What is Teresa Brophy Bair's net worth?

How old is Teresa Brophy Bair?

What is Teresa Brophy Bair's salary?

How do I contact Teresa Brophy Bair?

Has Teresa Brophy Bair been buying or selling shares of Kura Oncology?

Who are Kura Oncology's active insiders?

Are insiders buying or selling shares of Kura Oncology?